Victoza or Saxenda? The Honest Side-by-Side Comparison

Victoza at a glance:

• Drug class: GLP-1 receptor agonist
• Manufacturer: Novo Nordisk
• FDA approved: 2010
• Route: subcutaneous injection (multi-dose pen)
• Typical frequency: once daily
• Half-life: approximately 13 hours
• Cash price (US): $900-$1,100/month without insurance
• Receptor target: GLP-1 receptor

Head-to-head comparisons in this space are useful but easy to overweight. The truth is that most differences shake out to a couple of percentage points of efficacy and a different side-effect distribution. Here's how the two compare.

Mechanism

Victoza: Victoza is liraglutide dosed for type 2 diabetes — a once-daily GLP-1 receptor agonist.

Saxenda: Saxenda is liraglutide dosed for weight management. The same GLP-1 receptor agonist used for diabetes (Victoza) but titrated to a higher 3.0 mg/day target dose.

For people new to this comparison, the practical takeaway is that both work through similar pathways but have different pharmacokinetics.

Dosing & Administration

Effectiveness

Victoza: A1c reductions of 1.0-1.5% and modest weight loss (2-3 kg). Cardiovascular benefit in LEADER.

Saxenda: Mean weight loss of 8% of body weight at 56 weeks in SCALE trials — modest compared with semaglutide or tirzepatide.

In head-to-head comparisons (where they exist), the higher-dose newer agents tend to outperform older ones — sometimes meaningfully. Reference trials: LEADER (Marso 2016, NEJM) — 13% relative reduction in major cardiovascular events for Victoza; SCALE Obesity (Pi-Sunyer 2015, NEJM) — 9 for Saxenda.

Side Effects

The two compounds have overlapping side-effect profiles. Common to both:

• nausea
• diarrhea
• headache
• vomiting
• constipation
• injection-site reactions

Important risks worth knowing for both:

• pancreatitis
• thyroid C-cell tumors (boxed warning)
• gallbladder disease
• acute kidney injury

Cost

Victoza: $900-$1,100/month without insurance. Saxenda: $1,200-$1,400/month without insurance.

Insurance coverage and manufacturer programs change the relative cost picture significantly. See our individual cost guides for Victoza cost and Saxenda cost for the latest numbers.

Which Is Right for You?

The practical decision usually comes down to four factors:

1. What's covered by your insurance? Often the deciding factor
2. What does your prescriber have experience with? Familiarity reduces dosing errors
3. How comfortable are you with injections (or oral dosing if applicable)?
4. What's your tolerance for side effects?

If you and your clinician end up split between Victoza and Saxenda, either is a defensible choice in most cases.

Switching Between Them

Switching from Victoza to Saxenda (or the reverse) is usually straightforward but should be done with clinician guidance — particularly to align dose escalation and avoid GI side effects from re-titration.

Bottom Line

Head-to-head comparisons are useful but rarely decisive. The bigger swing factors are usually outside the comparison itself.

Frequently Asked Questions

Related Reading

• Victoza Explained: How It Works and Who It's For
• Victoza Side Effects Decoded: What's Normal vs. What Isn't
• What Results Should You Expect from Victoza? A Practical Guide
• Victoza Price Decoded: Insurance, Coupons, and Cash-Pay Options
• What Is Ozempic? Everything You Should Know Before Starting
• Is Ozempic Safe? An Honest Look at the Side-Effect Profile

Sources

• Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT). NEJM 2023;389:2221.
• Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989.
• Marso SP et al. Semaglutide and Cardiovascular Outcomes in Type 2 Diabetes (SUSTAIN-6). NEJM 2016;375:1834.

This page is informational only and is not a personalized recommendation. The right choice depends on your individual situation.